Hello and welcome to HotCopper Highlights, where we take a look at the stocks that had HotCopper investors talking this week.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
Stakk topped the most viewed list after updating the market with stronger earnings guidance and an optimistic outlook for the year ahead. Investors were debating whether the software company’s recent momentum can continue into FY27.
Northern Star was another stock firmly on traders’ radar. The gold miner bounced back into focus after confirming it had met annual production guidance, announcing a new chief executive and outlining progress on its major KCGM mill expansion project.
Rounding out the most viewed stocks was Echo IQ. The AI healthcare company continued attracting attention after its recent partnership with Pro Medicus, with investors now watching for commercial wins and broader adoption of its cardiac screening technology.
Over on the discussion boards, Imugene generated the most conversation. Traders continued debating the biotech’s clinical pipeline and upcoming trial milestones, with many seeing the next data release as a potential catalyst for the stock.
Liontown Resources also remained one of the forum’s busiest discussions. Investors were focused on the Kathleen Valley ramp-up, lithium prices and whether improving battery metals sentiment could finally mark a turning point for the sector.
And American Tungsten rounded out the most discussed list. The company stayed in the spotlight after recent high-grade antimony drilling results and moves to strengthen funding, with investors closely watching its strategy to become a key Western supplier of critical minerals.
That’s it for this week’s HotCopper Highlights. Thanks for watching, and we’ll see you next week.
Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.